They give the body the instructions it needs to repair, rebalance, and regenerate
The Phase 2 trial starting dose was 2 mg once weekly by subcutaneous injection, mirroring the initiation approach used with other incretin-based therapies
Management is entirely supportive: IV fluids for dehydration from vomiting, ondansetron (4 mg IV) for persistent nausea, and standard anaphylaxis protocols if allergic signs appear
It is expensive, but if you have tried everything and are not seeing results, this may be for you
Can Be Injected, Applied Topically, or Taken Orally Under Controlled Laboratory Environments
Progress photos in consistent lighting and posture, taken every 2-4 weeks, reveal changes that gradual daily observation misses